In NPM-c AML cells, ARF is unstable and can be degraded rapidly, whereas ULF knock-down can stabilize ARF and activate the ARF-p53 axis (Figure 3) (Table 2), making ULF an effective target in AML cells (Chen et al., 2010b). Here, TRIP12 is linked to acute myeloid leukemia.